DK0955314T3 - Peptidanaloge af glucagon-lignende-peptid-1 (7-37), fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger - Google Patents

Peptidanaloge af glucagon-lignende-peptid-1 (7-37), fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger

Info

Publication number: DK0955314T3
Authority: DK; Denmark
Prior art keywords: peptide; glucagon; preparation; pharmaceutical compositions; heteroarylcarbonyl
Prior art date: 1998-04-10

Application number

DK99400613T

Other languages

English (en)

Inventor

Dominique Manechez

Bernard Calas

Gerard Grassy

Alain Chavanieu

De Menthiere Cyril Sarrauste

Pierre Renard

Bruno Pfeiffer

Original Assignee

Servier Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-04-10

Filing date

1999-03-12

Publication date

2004-04-13

1999-03-12 Application filed by Servier Lab filed Critical Servier Lab

2004-04-13 Application granted granted Critical

2004-04-13 Publication of DK0955314T3 publication Critical patent/DK0955314T3/da

Links

GCYXWQUSHADNBF-AAEALURTSA-N preproglucagon 78-108 Chemical class C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 GCYXWQUSHADNBF-AAEALURTSA-N 0.000 title abstract 2
239000008194 pharmaceutical composition Substances 0.000 title 1
108090000765 processed proteins & peptides Proteins 0.000 title 1
125000005223 heteroarylcarbonyl group Chemical group 0.000 abstract 2
125000001424 substituent group Chemical group 0.000 abstract 2
101800004266 Glucagon-like peptide 1(7-37) Proteins 0.000 abstract 1
125000002252 acyl group Chemical group 0.000 abstract 1
239000000556 agonist Substances 0.000 abstract 1
125000003545 alkoxy group Chemical group 0.000 abstract 1
125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
125000000217 alkyl group Chemical group 0.000 abstract 1
125000000539 amino acid group Chemical group 0.000 abstract 1
125000003277 amino group Chemical group 0.000 abstract 1
125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 abstract 1
125000005098 aryl alkoxy carbonyl group Chemical group 0.000 abstract 1
125000005099 aryl alkyl carbonyl group Chemical group 0.000 abstract 1
125000005129 aryl carbonyl group Chemical group 0.000 abstract 1
125000005161 aryl oxy carbonyl group Chemical group 0.000 abstract 1
125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
229910052739 hydrogen Inorganic materials 0.000 abstract 1
239000001257 hydrogen Substances 0.000 abstract 1
125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
229940126601 medicinal product Drugs 0.000 abstract 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/605—Glucagons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Diabetes (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Endocrinology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Obesity (AREA)
Hematology (AREA)
Biochemistry (AREA)
Toxicology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Child & Adolescent Psychology (AREA)
Emergency Medicine (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

DK99400613T 1998-04-10 1999-03-12 Peptidanaloge af glucagon-lignende-peptid-1 (7-37), fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger DK0955314T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9804559A FR2777283B1 (fr)	1998-04-10	1998-04-10	Nouveaux composes peptidiques analogues du glucagon-peptide- 1 (7-37), leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number	Publication Date
DK0955314T3 true DK0955314T3 (da)	2004-04-13

Family

ID=9525150

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK99400613T DK0955314T3 (da)	1998-04-10	1999-03-12	Peptidanaloge af glucagon-lignende-peptid-1 (7-37), fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger

Country Status (18)

Country	Link
US (1)	US6620910B1 (da)
EP (1)	EP0955314B1 (da)
JP (1)	JP3787242B2 (da)
CN (1)	CN1305897C (da)
AT (1)	ATE255596T1 (da)
AU (1)	AU761652B2 (da)
BR (1)	BR9902014A (da)
CA (1)	CA2263059A1 (da)
DE (1)	DE69913242T2 (da)
DK (1)	DK0955314T3 (da)
ES (1)	ES2212485T3 (da)
FR (1)	FR2777283B1 (da)
HU (1)	HUP9900604A3 (da)
NO (1)	NO323137B1 (da)
NZ (1)	NZ334379A (da)
PL (1)	PL331960A1 (da)
PT (1)	PT955314E (da)
ZA (1)	ZA992035B (da)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7048906B2 (en)	1995-05-17	2006-05-23	Cedars-Sinai Medical Center	Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
EP1137667B1 (en) *	1998-12-07	2004-11-17	Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S.	Analogues of glp-1
PL208751B1 (pl) *	1998-12-07	2011-06-30	Sod Conseils Rech Applic	Związki stanowiące analogi GLP-1, kompozycje zawierające takie związki oraz zastosowanie takich związków
US9006175B2 (en)	1999-06-29	2015-04-14	Mannkind Corporation	Potentiation of glucose elimination
US7371721B2 (en)	2000-09-18	2008-05-13	Sanos Bioscience A/S	Use of GLP-2 and related compounds for the treatment, prevention, diagnosis, and prognosis of bone-related disorders and calcium homeostasis related syndromes
US7186683B2 (en)	2000-09-18	2007-03-06	Sanos Bioscience A/S	Use of GLP for the treatment, prevention, diagnosis, and prognosis of bone-related and nutrition-related disorders
PT1326630E (pt)	2000-09-18	2008-09-02	Sanos Bioscience As	Utilização de péptidos glp-2
GB0121709D0 (en) *	2001-09-07	2001-10-31	Imp College Innovations Ltd	Food inhibition agent
ES2320979T3 (es)	2001-09-24	2009-06-01	Imperial Innovations Limited	Pyy-36 para la reduccion o prevencion de la obesidad.
GEP20063908B (en) *	2001-10-18	2006-08-25	Bristol Myers Squibb Co	Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
US7238671B2 (en)	2001-10-18	2007-07-03	Bristol-Myers Squibb Company	Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
US7332819B2 (en) *	2002-01-09	2008-02-19	Micron Technology, Inc.	Stacked die in die BGA package
JP4733922B2 (ja)	2002-01-10	2011-07-27	インペリアル・イノベ−ションズ・リミテッド	摂食行動の修正
US8058233B2 (en) *	2002-01-10	2011-11-15	Oregon Health And Science University	Modification of feeding behavior using PYY and GLP-1
JP4681231B2 (ja)	2002-03-20	2011-05-11	マンカインドコーポレイション	吸入装置
US20080260838A1 (en) *	2003-08-01	2008-10-23	Mannkind Corporation	Glucagon-like peptide 1 (glp-1) pharmaceutical formulations
GB0300571D0 (en)	2003-01-10	2003-02-12	Imp College Innovations Ltd	Modification of feeding behaviour
EP2067483A1 (en) *	2003-02-19	2009-06-10	Ipsen Pharma	Analogues of GLP-1
US20040242568A1 (en)	2003-03-25	2004-12-02	Syrrx, Inc.	Dipeptidyl peptidase inhibitors
MXPA06001601A (es)	2003-08-13	2006-08-25	Takeda Pharmaceutical	Derivados de 4-pirimidona y su uso como inhibidores de dipeptidilpeptidasa.
US7169926B1 (en)	2003-08-13	2007-01-30	Takeda Pharmaceutical Company Limited	Dipeptidyl peptidase inhibitors
US7678909B1 (en)	2003-08-13	2010-03-16	Takeda Pharmaceutical Company Limited	Dipeptidyl peptidase inhibitors
WO2005026148A1 (en)	2003-09-08	2005-03-24	Takeda San Diego, Inc.	Dipeptidyl peptidase inhibitors
JP2007514752A (ja)	2003-12-16	2007-06-07	ソシエテ・ドゥ・コンセイユ・ドゥ・ルシェルシュ・エ・ダプリカーション・シャンティフィック・エス・ア・エス	Ｇｌｐ−１医薬組成物
EP1711523B1 (en)	2003-12-16	2012-10-10	Ipsen Pharma	Analogues of glp-1
US7732446B1 (en)	2004-03-11	2010-06-08	Takeda Pharmaceutical Company Limited	Dipeptidyl peptidase inhibitors
CN102079743B (zh)	2004-03-15	2020-08-25	武田药品工业株式会社	二肽基肽酶抑制剂
US7687638B2 (en)	2004-06-04	2010-03-30	Takeda San Diego, Inc.	Dipeptidyl peptidase inhibitors
WO2006019965A2 (en)	2004-07-16	2006-02-23	Takeda San Diego, Inc.	Dipeptidyl peptidase inhibitors
ATE486064T1 (de)	2004-08-20	2010-11-15	Mannkind Corp	Katalyse der diketopiperazinsynthese
HUE025151T2 (en)	2004-08-23	2016-01-28	Mannkind Corp	Diceto-piperazine salts for drug delivery
JP2008524331A (ja)	2004-12-21	2008-07-10	武田薬品工業株式会社	ジペプチジルペプチダーゼ阻害剤
TW200643033A (en) *	2005-03-08	2006-12-16	Chugai Pharmaceutical Co Ltd	Conjugate of water-soluble modified hyaluronic acid and glp-1 analogue
GB0511986D0 (en) *	2005-06-13	2005-07-20	Imp College Innovations Ltd	Novel compounds and their effects on feeding behaviour
MX373000B (es)	2005-09-14	2020-05-21	Mannkind Corp	Metodo para formulacion de farmaco basado en el aumento de la afinidad de agentes activos hacia las superficies de microparticulas cristalinas.
NZ566799A (en)	2005-09-14	2011-04-29	Takeda Pharmaceutical	Dipeptidyl peptidase inhibitors for treating diabetes
WO2007035629A2 (en)	2005-09-16	2007-03-29	Takeda Pharmaceutical Company Limited	Process for the preparation of pyrimidinedione derivatives
EP1943275B1 (en) *	2005-11-01	2010-06-16	Activotec SPP Limited	Insulinotropic compounds and uses thereof
GB0522295D0 (en) *	2005-11-01	2005-12-07	Activotec Spp Ltd	Peptides and uses thereof
CN104383546B (zh)	2006-02-22	2021-03-02	曼金德公司	用于改善包含二酮哌嗪和活性剂的微粒的药物性质的方法
CN1982336B (zh) *	2006-03-03	2011-01-12	华东师范大学	一种人胰高血糖素样肽-1衍生物及其制备和应用
US8324383B2 (en)	2006-09-13	2012-12-04	Takeda Pharmaceutical Company Limited	Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile
TW200838536A (en)	2006-11-29	2008-10-01	Takeda Pharmaceutical	Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
TWI428346B (zh)	2006-12-13	2014-03-01	Imp Innovations Ltd	新穎化合物及其等對進食行為影響
US8093236B2 (en)	2007-03-13	2012-01-10	Takeda Pharmaceuticals Company Limited	Weekly administration of dipeptidyl peptidase inhibitors
GB2448895A (en) *	2007-05-01	2008-11-05	Activotec Spp Ltd	GLP-1 like compounds and uses thereof
KR101736502B1 (ko) *	2007-10-24	2017-05-16	맨카인드 코포레이션	Ｇｌｐ-1에 의한 유해 효과의 예방 방법
US8485180B2 (en)	2008-06-13	2013-07-16	Mannkind Corporation	Dry powder drug delivery system
MY155524A (en)	2008-06-13	2015-10-30	Mannkind Corp	A dry powder inhaler and system for drug delivery
EP2609954B1 (en)	2008-06-20	2021-12-29	MannKind Corporation	An interactive apparatus for real-time profiling of inhalation efforts
TWI494123B (zh)	2008-08-11	2015-08-01	Mannkind Corp	超快起作用胰島素之用途
US8314106B2 (en)	2008-12-29	2012-11-20	Mannkind Corporation	Substituted diketopiperazine analogs for use as drug delivery agents
CN101463081B (zh) *	2009-01-12	2012-07-04	华东师范大学	一种glp-1衍生物
US8538707B2 (en)	2009-03-11	2013-09-17	Mannkind Corporation	Apparatus, system and method for measuring resistance of an inhaler
US8642544B2 (en)	2009-04-01	2014-02-04	Amylin Pharmaceuticals, Llc	N-terminus conformationally constrained GLP-1 receptor agonist compounds
AU2010259943C1 (en)	2009-06-12	2016-03-03	Mannkind Corporation	Diketopiperazine microparticles with defined specific surface areas
JP5784622B2 (ja)	2009-11-03	2015-09-24	マンカインドコーポレ−ション	吸入活動をシミュレートするための装置及び方法
RU2531455C2 (ru)	2010-06-21	2014-10-20	Маннкайнд Корпорейшн	Системы и способы доставки сухих порошковых лекарств
JP2013535471A (ja)	2010-07-28	2013-09-12	アミリン・ファーマシューティカルズ，リミテッド・ライアビリティ・カンパニー	安定化した領域を有するｇｌｐ−１受容体アゴニスト化合物
MX353285B (es)	2011-04-01	2018-01-05	Mannkind Corp	Paquete de blister para cartuchos farmaceuticos.
WO2012174472A1 (en)	2011-06-17	2012-12-20	Mannkind Corporation	High capacity diketopiperazine microparticles
HK1201475A1 (en)	2011-10-24	2015-09-04	Mannkind Corporation	Methods and compositions for treating pain
ES2810153T3 (es) *	2012-03-01	2021-03-08	Novo Nordisk As	Profármacos de GLP-1
AU2013289957B2 (en)	2012-07-12	2017-02-23	Mannkind Corporation	Dry powder drug delivery systems and methods
WO2014066856A1 (en)	2012-10-26	2014-05-01	Mannkind Corporation	Inhalable influenza vaccine compositions and methods
BR112015023168B1 (pt)	2013-03-15	2021-08-10	Mannkind Corporation	Composição de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina cristalina, método de produção de partículas de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina e uso de uma composição de dicetopiperazina cristalina
BR122019026637B1 (pt)	2013-07-18	2023-09-26	Mannkind Corporation	Formulações farmacêuticas de pó seco e método para a fabricação de uma formulação de pó seco
CA2920488C (en)	2013-08-05	2022-04-26	Mannkind Corporation	Insufflation apparatus and methods
US10307464B2 (en)	2014-03-28	2019-06-04	Mannkind Corporation	Use of ultrarapid acting insulin
US10561806B2 (en)	2014-10-02	2020-02-18	Mannkind Corporation	Mouthpiece cover for an inhaler
SMT202200352T1 (it)	2018-04-05	2022-09-14	Sun Pharmaceutical Ind Ltd	Analoghi del glp-1 innovativi
CN110070918B (zh) *	2019-04-02	2022-12-27	重庆邮电大学	基于分子间相互作用的粗粒化方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2113879T3 (es) *	1990-01-24	1998-05-16	Douglas I Buckley	Analogos de glp-1 utiles para el tratamiento de diabetes.
US5545618A (en) *	1990-01-24	1996-08-13	Buckley; Douglas I.	GLP-1 analogs useful for diabetes treatment
BR9306551A (pt) *	1992-06-15	1998-09-15	Pfizer	Derivados de peptídeo do tipo glucagona e de insulinotropina
CA2137206A1 (en) *	1993-12-09	1995-06-10	John A. Galloway	Glucagon-like insulinotropic peptides, compositions and methods
US5705483A (en) *	1993-12-09	1998-01-06	Eli Lilly And Company	Glucagon-like insulinotropic peptides, compositions and methods
WO1998043658A1 (en) *	1997-03-31	1998-10-08	Eli Lilly And Company	Glucagon-like peptide-1 analogs

1998
- 1998-04-10 FR FR9804559A patent/FR2777283B1/fr not_active Expired - Fee Related
1999
- 1999-02-25 NZ NZ334379A patent/NZ334379A/en unknown
- 1999-03-10 CA CA002263059A patent/CA2263059A1/fr not_active Abandoned
- 1999-03-11 NO NO19991199A patent/NO323137B1/no unknown
- 1999-03-12 DE DE69913242T patent/DE69913242T2/de not_active Expired - Fee Related
- 1999-03-12 AT AT99400613T patent/ATE255596T1/de not_active IP Right Cessation
- 1999-03-12 ES ES99400613T patent/ES2212485T3/es not_active Expired - Lifetime
- 1999-03-12 PL PL99331960A patent/PL331960A1/xx not_active IP Right Cessation
- 1999-03-12 EP EP99400613A patent/EP0955314B1/fr not_active Expired - Lifetime
- 1999-03-12 DK DK99400613T patent/DK0955314T3/da active
- 1999-03-12 JP JP06691799A patent/JP3787242B2/ja not_active Expired - Fee Related
- 1999-03-12 ZA ZA9902035A patent/ZA992035B/xx unknown
- 1999-03-12 HU HU9900604A patent/HUP9900604A3/hu unknown
- 1999-03-12 PT PT99400613T patent/PT955314E/pt unknown
- 1999-03-15 US US09/268,578 patent/US6620910B1/en not_active Expired - Fee Related
- 1999-03-15 CN CNB991039874A patent/CN1305897C/zh not_active Expired - Fee Related
- 1999-03-15 BR BR9902014-9A patent/BR9902014A/pt not_active Application Discontinuation
- 1999-04-09 AU AU23688/99A patent/AU761652B2/en not_active Ceased

Also Published As

Publication number	Publication date
EP0955314A2 (fr)	1999-11-10
ATE255596T1 (de)	2003-12-15
AU2368899A (en)	1999-10-21
NO991199D0 (no)	1999-03-11
US6620910B1 (en)	2003-09-16
PL331960A1 (en)	1999-10-11
CN1232038A (zh)	1999-10-20
ZA992035B (en)	1999-09-27
HUP9900604A2 (hu)	1999-09-28
CA2263059A1 (fr)	1999-10-10
PT955314E (pt)	2004-03-31
NO323137B1 (no)	2007-01-08
EP0955314B1 (fr)	2003-12-03
HK1022320A1 (en)	2000-08-04
NO991199L (no)	1999-10-11
HU9900604D0 (en)	1999-05-28
FR2777283A1 (fr)	1999-10-15
AU761652B2 (en)	2003-06-05
BR9902014A (pt)	2000-05-02
JPH11310597A (ja)	1999-11-09
DE69913242D1 (de)	2004-01-15
DE69913242T2 (de)	2004-09-09
CN1305897C (zh)	2007-03-21
FR2777283B1 (fr)	2000-11-24
HUP9900604A3 (en)	2001-01-29
NZ334379A (en)	1999-10-28
EP0955314A3 (fr)	2000-03-29
ES2212485T3 (es)	2004-07-16
JP3787242B2 (ja)	2006-06-21

Publication	Publication Date	Title
HU9900604D0 (en)	1999-05-28	New peptide compounds that are analogues of the glucagon-like peptide-1 (7-37), a process for their preparation and pharmaceutical compositions containing them
US5932733A (en)	1999-08-03	3-amino-2-oxo-1-piperidineacetic derivatives containing an arginine mimic as enzyme inhibitors
US6444817B1 (en)	2002-09-03	Thrombin inhibitors
MY140057A (en)	2009-11-30	Novel heterocyclic compounds having hypolipidemic, hypocholesteremic activities process for their preparation and pharmaceutical compositions containing them and their use in medicine
AU2001280438A1 (en)	2002-02-13	Substituted heterocyclic amides
AU2055500A (en)	2000-07-31	Aromatic amides
DE69831868D1 (en)	2006-02-23	Antithrombosemittel
EP2015769A4 (en)	2013-12-25	PHARMACEUTICAL COMPOSITIONS OF HGLP-1, EXENDINE 4 AND THEIR ANALOGUES
MXPA02012033A (es)	2003-04-25	Derivados de 2-aminocarbonil-9h-purina.
ATE326453T1 (de)	2006-06-15	Antithrombotische amide
JP2009521441A5 (da)	2010-02-12
WO2003084936A3 (en)	2004-03-18	Amino substituted pyrimidinone derivatives useful in the treatment of inflammation and immunological
JP2005531540A (ja)	2005-10-20	セリンプロテアーゼ阻害剤のスマートプロドラッグ
AU2364000A (en)	2000-07-31	Heterocyclic amides as inhibitors of factor xa
YU41199A (sh)	2001-09-28	Hinoksalindioni
WO2001053257A3 (en)	2002-06-27	Compounds having hypolipedemic and hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them
NZ276600A (en)	1997-09-22	2-acylpyrrolidines; compounds, preparation and pharmaceutical compositions
DE60114640D1 (en)	2005-12-08	Antithrombosemittel
MX2009004619A (es)	2009-05-15	Agonistas selectivos del receptor tiroideo (tr) beta 1.
HUT54385A (en)	1991-02-28	Process for producing renin-inhibitor peptides and pharmaceutical compositions containing them
SK85598A3 (en)	1998-12-02	Novel process for preparing n-acetyl(l)-4-cyanophenylalanine ac-(l)-phe(4-cn)-oh and n-acetyl-(l)-p-amidinophenylalanine- -cyclohexylglycine-'beta'-(3-n-methylpyridinium)-alanine ac- -(l)-paph-chg-palme(3)-nh2
GEP20074100B (en)	2007-05-10	Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising the same
HU189268B (en)	1986-06-30	Process for the semisynthetic preparation of humane insuline
IL109744A0 (en)	1994-08-26	3-(indol-3-yl) propenoic acid derivatives and pharmaceutical compositions thereof
DE69827614D1 (de)	2004-12-23	Chinoxalindionen